Inventor
HESTIR KEVIN
US16 patents
⚠️ This page may combine multiple inventors who share the name “HESTIR KEVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FIVE PRIME THERAPEUTICS INC
10 patentsUS9765147B2Sep 19, 2017
Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer
FIVE PRIME THERAPEUTICS INC25 citations93
US7776564B2Aug 17, 2010
Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
FIVE PRIME THERAPEUTICS INC15 citations89
US10618967B2Apr 14, 2020
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
FIVE PRIME THERAPEUTICS INC5 citations83
US10221244B2Mar 5, 2019
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
FIVE PRIME THERAPEUTICS INC10 citations83
US11566076B2Jan 31, 2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
FIVE PRIME THERAPEUTICS INC0 citations61
US9192683B2Nov 24, 2015
Methods of treating disease with FGFR1 fusion proteins
FIVE PRIME THERAPEUTICS INC0 citations51
US9173957B2Nov 3, 2015
FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIIC
FIVE PRIME THERAPEUTICS INC0 citations51
US10537611B2Jan 21, 2020
Methods of treating lung cancer
FIVE PRIME THERAPEUTICS INC0 citations48
US10016484B2Jul 10, 2018
Methods of treating lung cancer
FIVE PRIME THERAPEUTICS INC0 citations48
US11421034B2Aug 23, 2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
FIVE PRIME THERAPEUTICS INC0 citations46